We need to embrace these tests to stop overtreating prostate cancer

Professor David Gillatt

Urology has evolved dramatically over the course of my 30-year career, with exciting advances in prostate cancer treatment.

Most healthcare professionals will be familiar with the prostate-specific antigen (PSA) test. However, although it’s prostate specific, it’s not prostate-cancer specific.